Alnylam Pharmaceuticals, Inc. Forecast and Target Price
$461
Alnylam Pharmaceuticals, Inc. (ALNY) Share Price Forecast
Currently 34 wall-street analysts regularly analyze the financials of Alnylam Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals, Inc. (ALNY) have a share price target of $438.98. This median of share price forecast represents a -4.78% downside from the latest price of $461 as on 18.09.25.
Alnylam Pharmaceuticals, Inc. (ALNY) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Alnylam Pharmaceuticals, Inc. (ALNY) share price will touch around $438.98 in next 12-months.
Alnylam Pharmaceuticals, Inc. (ALNY) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Alnylam Pharmaceuticals, Inc.'s share price and its median forecast price. As on 18.09.25, the difference is -5.26%
Alnylam Pharmaceuticals, Inc. (ALNY): Difference between Current Price & Median Forecasted Price
Alnylam Pharmaceuticals, Inc. (ALNY) Share Price : Analyst Recommendation
Based on 34 analysts tracking and researching Alnylam Pharmaceuticals, Inc. (ALNY) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 17 | 16 | 16 |
| Outperform | 8 | 8 | 8 |
| Hold | 8 | 10 | 10 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |